Caris Life Sciences’ $830 Million Growth Equity Round

Shearman & Sterling represented Caris Life Sciences Inc. in the transaction.Caris Life Sciences Inc. executed an $830 million growth equity round. As a result of the…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here